1] McEwen Centre for Regenerative Medicine, University Health Network, Toronto, Ontario, Canada. [2] Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Nat Biotechnol. 2015 Jun;33(6):638-45. doi: 10.1038/nbt.3210. Epub 2015 May 11.
The replacement of articular cartilage through transplantation of chondrogenic cells or preformed cartilage tissue represents a potential new avenue for the treatment of degenerative joint diseases. Although many studies have described differentiation of human pluripotent stem cells (hPSCs) to the chondrogenic lineage, the generation of chondrocytes able to produce stable articular cartilage in vivo has not been demonstrated. Here we show that activation of the TGFβ pathway in hPSC-derived chondrogenic progenitors promotes the efficient development of articular chondrocytes that can form stable cartilage tissue in vitro and in vivo. In contrast, chondrocytes specified by BMP4 signaling display characteristics of hypertrophy and give rise to cartilage tissues that initiate the endochondral ossification process in vivo. These findings provide a simple serum-free and efficient approach for the routine generation of hPSC-derived articular chondrocytes for modeling diseases of the joint and developing cell therapy approaches to treat them.
通过将成软骨细胞或预制软骨组织移植到关节中来替代关节软骨,代表了治疗退行性关节疾病的一种新的潜在途径。尽管许多研究已经描述了人类多能干细胞(hPSC)向成软骨谱系的分化,但尚未证明能够在体内产生能够产生稳定关节软骨的软骨细胞。在这里,我们表明,在 hPSC 衍生的软骨祖细胞中激活 TGFβ 途径可促进高效发育关节软骨细胞,这些细胞可以在体外和体内形成稳定的软骨组织。相比之下,由 BMP4 信号指定的软骨细胞表现出肥大的特征,并产生在体内启动软骨内骨化过程的软骨组织。这些发现为常规生成用于模拟关节疾病和开发细胞治疗方法来治疗这些疾病的 hPSC 衍生关节软骨细胞提供了一种简单的无血清和高效的方法。